Provided by Tiger Trade Technology Pte. Ltd.

Adial Pharmaceuticals

5.79
+0.19003.39%
Volume:64.97K
Turnover:365.23K
Market Cap:15.20M
PE:-0.33
High:5.98
Open:5.57
Low:5.30
Close:5.60
52wk High:10.75
52wk Low:1.31
Shares:2.63M
Float Shares:2.13M
Volume Ratio:1.00
T/O Rate:3.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.7100
EPS(LYR):-11.9306
ROE:-2011.64%
ROA:-40.02%
PB:-0.40
PE(LYR):-0.49

Loading ...

Adial Pharmaceuticals files to sell 25.15M shares of common stock for holders

TIPRANKS
·
Aug 29

Adial Pharmaceuticals - Proposed Resale of up to 25,148,970 Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Aug 29

Adial Pharma Grants Unregistered Option for 307,814 Shares at $5.76 Per Share

Reuters
·
Aug 26

Adial Pharmaceuticals Grants Inducement Stock Options to New Hire

TIPRANKS
·
Aug 26

Adial Pharmaceuticals Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 26

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 26

Adial Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 25

Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge

TIPRANKS
·
Aug 22

Adial Pharmaceuticals Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Minimum

Reuters
·
Aug 22

U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies

Reuters
·
Aug 17

U.S. Stocks on the MOVE - KBR, Vista Energy, Fulcrum Therapeutics

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 EPS $(11.25)

Benzinga Earnings
·
Aug 17

Adial Pharmaceuticals Falls After Quarterly Loss Widens

Reuters
·
Aug 17

Adial Pharmaceuticals Posts Bigger-than-Expected Q2 Net Loss, Hurt by Acquisition Charges

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 Net Income USD -52 Million

THOMSON REUTERS
·
Aug 17

Press Release: Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Dow Jones
·
Aug 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 17

Adial Pharma Faces Governance Risks and Major Dilution as 2026 Shareholder Vote Looms on Preferred Conversions and Warrants

TIPRANKS
·
Aug 16

Adial Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Adial Q2 Net Loss Widens to $51.99 Million from Year-Ago Quarter

Reuters
·
Aug 15